Bharat Biotech's Covaxin on UK’s approved list of Covid-19 vaccines

By Jasleen Kaur -- November 22, 2021 9:11 pm -- Updated:Feb 15, 2021

From November 22, Bharat Biotech's Covaxin, one of the vaccines being given in India to protect against Covid-19, has been put on the UK’s list of approved vaccines for international travellers.

It comes as a major relief for fully vaccinated international travelers, especially Indians, planning travel to the UK without the need for a pre-departure RT-PCR test or self-isolation at the address declared on their compulsory passenger locator forms.

WHO on approval for Covaxin: Additional clarifications needed from Bharat  Biotech for final assessment - Coronavirus Outbreak News

Also read | Punjab Assembly elections 2022: AAP promises 1,000 for each woman over 18 yrs of age per month if voted to power

Like other fully vaccinated travellers, including those vaccinated with Covishield, Indian travellers are required to pre-book a RT-PCR or Lateral Flow Test on arrival in England, to be taken before the end of Day 2.

“From 4 am on Monday 22 November, the government will recognise vaccines on the World Health Organisation’s Emergency Use Listing (WHO EUL) at the border,” the UK’s Department for Transport confirmed.

Covaxin: WHO approves Bharat Biotech's Covid vaccine for emergency use  listing

Also read | From November 26, Airtel prepaid tariff to be up by 25 per cent

“As a result, Sinovac, Sinopharm Beijing and Covaxin will be added to our existing list of approved vaccine for inbound travel, benefitting more fully vaccinated passengers,” it said.

Earlier, Bharat Biotech's Covaxin had received its WHO EUL status, resulting in the UK announcing plans to include it on its list of approved Covid vaccines from November 22.

New Zealand Recognises Covishield, Covaxin; India Waits For Announcement on  Lifting of Travel Curbs

-PTC News with agency inputs

  • Share